You didn't pay attention to anything I posted. Let
Post# of 148174
I asked Cdiddy if *he* thinks the results from the interim analysis will be underwhelming because *he* said it's most likely that we, the investment community, will not see the interim data.
The question I posed has nothing to do with you. I was asking something specific to CDiddy for why he believes it's unlikely we'll see the interim data, and we'll have to wait for the full trial.
Maybe because the data for half the trial will be underwhelming based on sample size, maybe because the FDA would like to see the full trial results irrespective of the interim analysis.
Either way, this is a question for him as I'm asking why *he* believes it's not likely we'll see the interim data. *I'm* not opining on anything.
Next time, read what it is I wrote so you don't foolishly start implying things I never said.
I expect the interim data to be good and was curious why he believes we will most likely have to wait to see the results until full enrollment is completed.